COVID-19: impact of and on diabetes

Jonathan Schofield, Lalantha Leelarathna, Hood Thabit

Diabetes Ther. 2020 Jul; 11(7): 1429–143

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275119/

 

Notas de esclarecimentos da Sociedade Brasileira de Diabetes sobre o coronavirus (COVID-19)

https://www.diabetes.org.br/publico/notas-de-esclarecimentos-da-sociedade-brasileira-de-diabetes-sobre-o-coronavirus-covid-19

 

Síndrome metabólica e COVID-19: onde as vias se cruzam

L R Giacaglia

https://www.diabetes.org.br/covid-19/sindrome-metabolica-e-covid-19-onde-as-vias-se-cruzam/

 

COVID-19 and diabetes: knowledge in progress

Akhtar Hussain, Bishwajit Bhowmik, Nayla Cristina do Vale Moreira

Diabetes Res Clin Pract. 2020 Apr; 162: 10814

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144611/

 

Type 2 diabetes as a major risk factor for COVID-19 severity: a meta-analysis

Pinto, Lana C. and Bertoluci, Marcello C

Arch. Endocrinol. Metab., June 2020, vol.64, no.3, p.199-200

https://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972020000300199&lng=en&nrm=iso

 

COVID-19 and diabetes mellitus: an unholy interaction of two pandemicas

Rimesh Pal, Sanjay K. Bhadada

Diabetes Metab Syndr. 2020 July-August; 14(4): 513–51

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7202837/

 

SARS-CoV-2 disease severity and diabetes: why the connection and what is to be done?

Caio Henrique Mazucanti, Josephine Mary Egan

Immun Ageing. 2020; 17: 21

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325192/

 

Glycaemic control among people with type 1 diabetes during lockdown for the SARS-CoV-2 outbreak in Italy

Benedetta Maria Bonora, Federico Boscari, Angelo Avogaro et al

Diabetes Ther. 2020 Jun; 11(6): 1369–1379

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213551/

 

Risk and predictors of in-hospital mortality from COVID-19 in patients with diabetes and cardiovascular disease

Hadith Rastad, Hossein Karim, Hanieh-Sadat Ejtahed, et al

Diabetol Metab Syndr. 2020; 12: 57

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338100/

 

Low dose chloroquine decreases insulin resistance in human metabolic syndrome but does not reduce carotid intima-media thickness

Janet B. McGill, Mariko Johnson, Stacy Hurst, et al

Diabetol Metab Syndr. 2019; 11: 61

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664523/

 

Diabetes, infection risk and COVID-19

Suheda Erener

Mol Metab. 2020 Jun 23 : 101044

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308743/

 

■  Dr Paulo Fernando Leite

Cardiologia/Prevenção Cardiovascular

Estratificação de Risco Cardiovascular

Consultório: Rua Padre Rolim 815/sala 601 – Belo Horizonte/MG/Brasil

Tel: 33245518

CRMMG: 7026

Email: pfleite1873@gmail.com

Blog Internet Médica – www.internetmedica.com.br

Data: julho 2020